Primary study · included by 1 review
Systematic evaluation of salivary gland damage following I-131 therapy in differentiated thyroid cancer patients by quantitative scintigraphy and clinical follow-up.
Wu Feng 2015 · Wu Ju-qing, Feng Hui-juan, Ouyang Wei, et al. · Nuclear medicine communications · 2015
Included by
| Outcome this study informs | Pooled effect | Evidence | Certainty |
|---|---|---|---|
Xerostomia High administered I131 activity (study-specific thresholds) vs Low administered I131 activity (study-specific thresholds) | OR 7.14 [2.02, 25.26] | 3 studies | GRADE not reported |
Xerostomia (pooled prevalence) Radioiodine (I131) therapy · between 2 and 6 months after RIT | Prevalence 0.37 [0.28, 0.47] | 4 studies · 392 participants | GRADE not reported |
Xerostomia High administered I131 activity (study-specific thresholds) vs Low administered I131 activity (study-specific thresholds) | OR 4.23 [1.04, 17.15] | 4 studies | GRADE not reported |
1 including review in total.